Quantitative analysis demonstrated that LA@BC-treated cells exhibited 30% lower iNOS fluorescence intensity and 1.5-fold higher CD206 fluorescence intensity compared to Control and BC groups, indicating a shift toward M2 polarization (Figures 4B, C). This evidence concerns the gene MRC1 and breast cancer.